About Dan Zabrowski
Dan Zabrowski is a director at Actuate Therapeutics.
Dan Zabrowski reports to the SEC as a director of 2 public companies, including Apexigen (APGN).
Dan Zabrowski first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Dan Zabrowski in the role, so the role may have started earlier or lasted longer.
AI
Apexigen, Inc.
Director
2022 – 2023 · Public company (APGN)
Key Colleagues at Startups
The people Dan Zabrowski works with at each company, as listed on that company's latest Form D.
Actuate Therapeutics, Inc. · Form D, Jul 7, 2025
TT
Todd Thomson
Director
DS
Daniel Schmitt
Executive officer and director
PL
Paul Lytle
Chief Financial Officer
RS
Roger Sawhney
Director
AM
Andrew Mazar
Executive officer
AR
Amy Ronneberg
Director
JK
Jason Keyes
Director
AF
Aaron Fletcher
Director